论文部分内容阅读
我科自1988年8月至1992年3月间,采用DFP和DFP+CF方案,治疗随机分为2组的晚期食管癌、贲门癌59例,现将两方案近期疗效进行比较,结果报告如下。 临床资料 (一)一般资料:全部病例均经病理组织学和(或)细胞学确诊,并有可测量的肿瘤,能客观判定疗效。DFP组(甲组)31例,其中男性23例,女性8例,年龄32～78岁,中位年龄65.3岁。食管癌25例(中上段癌1例,中段癌22例,下段癌2例)、鳞癌24例,腺癌1例。贲门癌6例均为腺癌。初发者2例,放疗后
In our department from August 1988 to March 1992, the DFP and DFP+CF regimens were used to treat 59 cases of advanced esophageal and cardiac cancers randomly divided into 2 groups. The short-term efficacy of the two regimens is now compared. The results are reported below. . Clinical data (1) General information: All cases were confirmed by histopathology and/or cytology, and there were measurable tumors that could objectively determine the efficacy. There were 31 patients in the DFP group (Group A), including 23 males and 8 females, aged 32-78 years, and median age 65.3 years. There were 25 cases of esophageal cancer (1 in the middle and upper segment, 22 in the middle segment, and 2 in the lower segment), 24 in the squamous cell carcinoma, and 1 in the adenocarcinoma. Cardiac cancer was adenocarcinoma in 6 cases. 2 cases of first-episode, after radiotherapy